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a b s t r a c t
As is the case for nearly every viral pathogen, non-enveloped viruses (NEV) must maintain their integrity
under potentially harsh environmental conditions while retaining the ability to undergo rapid
disassembly at the right time and right place inside host cells. NEVs generally exist in this metastable
state until they encounter key cellular stimuli such as membrane receptors, decreased intracellular pH,
digestion by cellular proteases, or a combination of these factors. These stimuli trigger conformational
changes in the viral capsid that exposes a sequestered membrane-perturbing protein. This protein
subsequently modiﬁes the cell membrane in such a way as to allow passage of the virion and
accompanying nucleic acid payload into the cell cytoplasm. Different NEVs employ variations of this
general pathway for cell entry (Moyer and Nemerow, 2011, Curr. Opin. Virol., 1, 44–49), however this
review will focus on signiﬁcant new knowledge obtained on cell entry by human adenovirus (HAdV).
& 2015 Elsevier Inc. All rights reserved.
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Introduction
There are more than 60 different types of human adenovirus
belonging to 6 distinct subgroups (A–G) (King et al., 2012; Liu
et al., 2012) and many of these are associated with acute
respiratory, gastrointestinal and ocular infections. Although
usually self-limiting, these infections can lead to fatal dissemi-
nated infections in immunocompromised individuals (Lion, 2014).
Conditionally-replicating (i.e., oncolytic) or replication-defective
adenoviruses are now well known for their use in gene transfer or
vaccine delivery. However, optimal targeting to speciﬁc cell types
remains an unresolved goal. Thus, an understanding of complex
interactions of HAdV with the host is crucial. Over the past several
years, detailed knowledge of cell entry by this relatively large
(150 MDa) virus has been obtained and some of its most closely
held secrets have been revealed. These include the mechanism of
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virus internalization, the location and structure of the virus
membrane lytic protein inside the virus capsid, as well as the
host immune and cellular responses triggered by HAdV cell entry.
Receptor-mediated virus attachment and internalization
Due to its size and complexity, HAdV presents signiﬁcant
challenges for studying its mode of cell entry. This naked virus is
90 nm in diameter and contains a 36-KB dsDNA genome
encoding 13 distinct structural proteins including a cysteine
protease whose activity is required for capsid maturation (Fig. 1).
Each of the 12 vertices of the virus possess two major outer capsid
proteins known as the ﬁber (van Raaij et al., 1999) and penton base
(Zubieta et al., 2005; Wickham et al., 1993) that serve as attach-
ment and internalization receptor binding proteins, respectively.
Attachment of most HAdV types is mediated by a cell receptor
known as the Coxsackie and Adenovirus Receptor (CAR), a mem-
ber of the Ig superfamily (Bergelson et al., 1997). CAR plays a role
in maintaining the integrity of tight junctions in polarized epithe-
lial cells and is normally sequestered on the basolateral surface of
these cells (Walters et al., 2002). This situation has hindered the
use of Ad gene delivery for treatment of human airway diseases
(Zabner et al., 1997; Walters et al., 1999). However, a single isoform
of HCAR, designated CAREx8, appears to trafﬁc to the apical surface
of airway epithelial cells and allows a modest level of HAdV
infection from this location (Excoffon et al., 2010). Interestingly,
on certain cell types such as motor neurons, CAR can serve as both
an attachment receptor as well as an internalization to promote
virus uptake (Salinas et al., 2009; Salinas et al., 2014).
As noted above, not all species of HAdV use CAR as their
primary receptor. For example, the ﬁber proteins of certain
subgroup B adenoviruses including types 3, 7, 11 and 14 use
desmoglein-2 (DSG-2) as a high afﬁnity attachment receptor
(Wang et al., 2011). DSG-2 ligation can regulate access to epithelial
cell junctions and thus the use of type B Ad vectors that recognize
this receptor may prove useful for targeting oncolytic HAdV to
tumor cells. The ﬁber proteins of other subgroup B viruses
including Ad types 35 and 16, have been shown to use CD46, a
complement regulatory protein family member, for cell attach-
ment (Gaggar et al., 2003). Virus types such as Ad19 and Ad37
associated with epidemic keratoconjunctivitis, a serious ocular
disease, bind to α2,3-linked sialic acid (Arnberg et al., 2000;
Nilsson et al., 2011) or CD46 (Wu et al., 2004). These cell receptors
are widely distributed on various cell types in vivo, and thus their
presence on certain tissues does not readily explain adenovirus
tropism. Nonetheless, signiﬁcant progress has been made in
elucidating the structural basis of Ad ﬁber interactions with CAR
Fig. 1. Structure and organization of human adenovirus. (A) A schematic illustration of the organization of capsid and core proteins in human adenovirus. The locations of
various proteins are represented by different-colored symbols and the corresponding names are shown (Right). The indicated locations of the core proteins are approximate.
Shown in blue-colored lettering are the proteins whose structures have been identiﬁed in this study. (B) Overall organization of hexon and penton base subunits exhibiting
pseudo-T¼25 icosahedral symmetry. Structurally unique hexons (1–4) are color-coded in light blue, pink, green, and khaki, respectively. Penton vertices are shown in
magenta. Outer cement proteins IIIa and IX are shown in purple and blue, respectively. Fiber molecules associated with the penton base are disordered. The outline of the
triangular icosahedral facet is shown as a gray triangle, whereas the border of the GON hexons is indicated by yellow-colored rope. (C) An exterior view of the triangular
icosahedral facet that comprises 12 hexons along with penton base vertices shown in magenta. Color representations are the same as in B. (D) An interior view of the facet in
C, with three minor proteins, V (green), VI (red), and VIII (orange). It is noteworthy that a copy of V, VI, and VIII forms a ternary complex beneath the vertices, whereas VIII
(orange) molecules are arranged as staples along the border (yellow-colored rope) of the GON hexons. Reddy V S, and Nemerow G R. PNAS 2014;111:11715–11720.
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(Seiradake et al., 2006; Bewley et al., 1999), CD46 (Persson et al.,
2007; Pache et al., 2008; Cupelli et al., 2010), and sialic acid
(Burmeister et al., 2004). In addition to speciﬁc amino acid
sequences present in the ﬁber knob domain that mediate receptor
interaction, the length and ﬂexibility of the ﬁber shaft domain also
play roles in receptor usage (Wu et al., 2004). These structural,
biochemical, and functional studies continue to foster the devel-
opment of chimeric/recombinant HAdV vectors with unique cell
receptor speciﬁties (Schagen et al., 2006).
The vitronectin-binding integrins αvβ3 and αvβ5 promote HAdV2
internalization but not cell attachment (Wickham et al., 1993). αv
integrins bind to an extended and ﬂexible loop on the virus penton
base that contains an arginine, glycine, aspartic acid (RGD) sequence
(Stewart et al., 1997) (Fig. 2) and facilitate virus uptake into clathrin-
coated early endosomes (Wang et al., 1998). Virus uptake appears to
be stimulated by cell signaling events that involve activation of PI3K
and rearrangement of the actin cystoskeleton (Li et al., 1998). It is also
possible that integrin-mediated signaling events enhance adenovirus
cell entry via macropinocytosis (Amstutz et al., 2008). More recent
ﬂuorescence microscopy studies showed that the different physical
motions of CAR and integrins in the cell plasma membrane following
virus interactions, may initiate disassembly of the virus particle even
before it reaches the early endosome (Burckhardt et al., 2011). In
keeping with this possibility, cryoelectron microscopy structural
studies of a complex of integrin αvβ5 bound to HAdV revealed a
subtle conformational change in the penton base (i.e. clockwise twist)
that could represent the initial changes in the viral vertex region
associated with the capsid disassembly process (Lindert et al., 2009).
Despite the accumulating knowledge of HAdV cell receptors in
cell culture systems, the host factors that regulate HAdV cell
tropism and immune responses in vivo are considerably more
complex. This was brought into focus by the tragic death of a
patient in a gene therapy clinical trial for liver disease using
systemic delivery of an adenoviral vector (Raper et al., 2003). It
was subsequently discovered that HAdV5-mediated gene delivery
to the liver occurs without the use of CAR or integrins (Smith,
2003). Instead, coagulation factor X (FX) was shown to mediate
Ad5 vector binding to hepatocytes (Waddington et al., 2008;
Kalyuzhniy et al., 2008). In this situation, the γ-carboxy glutamic
acid domain of FX binds to the hexon protein of Ad5 and this
allows association of the C-terminal serine protease domain of FX
with cell surface heparin-sulfated molecules (Waddington et al.,
2008). More recent studies have also suggested that the binding of
FX to the HAdV5 capsid may restrict coating of the capsid by IgM
and complement components, thereby enhancing hepatocyte
interactions (Xu et al., 2013). Taken together, these in vivo studies
illustrate the diverse modes of HAdV–tissue interactions and serve
as a reminder of the safety concerns of adenoviral vectors.
Membrane disruption (historical perspective)
After attachment to cells, early electron microscopy studies
showed that adenovirus is endocytosed and that a largely intact
capsid gains access to the cytoplasm (Morgan et al., 1969).
Adenovirus was initially presumed to cause global disruption of
cell membranes in a manner distinct from other nonenveloped
viruses (e.g. picornaviruses). This observation was based on the
capacity of virions to permeabilize cell membranes to small ions
like chromium and choline (Seth et al., 1984; Seth et al., 1985), as
well as to larger molecules such as alpha-sarcin (16 kDa) (Wiethoff
et al., 2005) and ﬂuorescent dextrans (70 kDa FITC-dextran)
(Prchla et al., 1995) and even a 25 nm diameter mutant parvovirus
defective in endosomal escape (Farr et al., 2005). From these
studies it was concluded that adenovirus induced large-scale
fragmentation of cell membranes rather than formation of discrete
pores. Early studies did not reveal the speciﬁc site of membrane
disruption during cell entry. However, negative stain-electron
microscopy and immunoﬂuorescence microscopic analyses as well
as the use of chemical inhibitors of endosomal acidiﬁcation
supported the idea that endosomal membranes were the sites of
membrane damage (Morgan et al., 1969; FitzGerald et al., 1983;
Greber et al., 1993). In one study, ﬂow cytometric analyses showed
a decrease in the number of endosomes obtained from cells after
adenovirus cell entry, leading the authors to suggest that adeno-
virus ruptured endosomes in order to gain access to the cytoplasm
(Brabec et al., 2005).
Initial studies of adenovirus permeablization of cell membranes
showed that virus-mediated release of small ions was augmented
at lower pH. This was in agreement with previous observations
that adenovirus escape from endosomes into the cytoplasm could
be inhibited by pharmacological inhibition of endosomal acidiﬁca-
tion (Seth et al., 1984). Thus, early on it was proposed that
adenovirus membrane penetration was a pH dependent process.
Later studies however suggested that pharmacological inhibition
of endosomal acidiﬁcation did not affect adenovirus cell entry or
that low pH may impact an event upstream of endosomal escape
such as endocytosis or endosomal trafﬁcking (Rodríguez and
Everitt, 1996; Pérez and Carrasco, 1994). Such events could include
the partial disassembly of the adenovirus capsid, a step necessary
for endosomal escape. However, more recent studies have con-
cluded that, at least in the case of subgroup C adenovirus, capsid
disassembly may be initially induced at the cell surface in a
manner dependent on the dual engagement of mobile Coxsack-
ievirus and Adenovirus Receptor and the less mobile αV integrins
(Burckhardt et al., 2011).
Studies employing a temperature sensitive mutant of human
adenovirus 2, H2ts1 (ts1), suggested that structural lability (com-
monly referred to as metastable) of the capsid is required for cell
membrane penetration. The ts1 capsids produced at the nonper-
missive temperature are known to be hyperstable and incapable of
releasing vertex proteins upon heating or when incubated at low
pH, in contrast to what is observed for capsids formed at the
Fig. 2. CryoEM structure of Ad12 complexed with a soluble recombinant form of
integrin αvβ5. The structure is shown artistically as if one virion were interacting
with a host cell in the foreground. A second Ad virion with modeled full-length
ﬁbers is shown in the distance. The cryoEM structure revealed a compact ring of
integrin density over each penton base (yellow) with the RGD-loop (surface
protrusions) spacing of the penton base promoting interaction between integrin
heterodimers (red) (bottom). Segmented density regions corresponding roughly to
individual integrin molecules are shown in solution on the lower left. Copyright
American Society for Microbiology, Journal of Virology, Volume 73, Number 8, p.
6759–6768, cover image, 1999. G.R. Nemerow, L. Pache, V. Reddy, P.L. Stewart.
Virology, Volume 384, Issue 2, 2009, 380–388.
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permissive temperature (Hannan et al., 1983). Structural studies
have demonstrated that this enhanced stability of the ts1 capsid is
related to a more intimate association between the capsid proteins
near the vertex and the DNA core (Silvestry et al., 2009). Electron
microscopic studies demonstrated that, when grown at the non-
permissive temperature, the ts1 virion failed to escape cell endo-
somes (Miles et al., 1980; Greber et al., 1996). Further studies
provided biochemical evidence that ts1 could not permeabilize cell
membranes to small ions or larger biomolecules (Wiethoff et al.,
2005; Cotten and Weber, 1995). The defect in cell membrane
permeablization by the ts1 mutant was conﬁrmed by studies
demonstrating the failure of this mutant virus to permeabilize
model liposomal membranes to small molecular weight ﬂuoro-
phores in the absence of cellular receptors or other factors
(Wiethoff et al., 2005).
Discovery of protein VI membrane lytic activity
While considerable effort has gone into the study of how
adenovirus disrupts cellular membranes to gain access to the
cytoplasm and nucleus, prior to 2005 there has been little
conclusive evidence that one or more of the 13 structural proteins
of the virion mediate membrane rupture. Some of the ﬁrst studies
aimed at identifying the membrane lytic protein of the adenovirus
capsid used antibodies against the penton base and hexon to
assess their role in cellular membrane permeablization. When the
virus was added to cells loaded with radiolabeled choline in the
presence of anti-penton base antibodies, release of radioactivity
into the cell supernatant was greatly reduced suggesting that the
penton base was involved in membrane rupture (Seth, 1994).
Other studies demonstrated that when viruses were mixed with
liposomes, these lipid membranes were bound at the vertex of the
virions, suggesting that the penton could be involved in
membrane lysis.
Attempts to demonstrate that recombinant penton base was
capable of permeabilizing artiﬁcial liposomal membranes were
unsuccessful, as we were unable to observe any membrane lytic
activity compared to puriﬁed virions that efﬁciently disrupted
membranes (Wiethoff and Nemerow, unpublished observations
and (Wiethoff et al., 2005)). However, when mixed with lipo-
somes, we observed membrane permeabilization only when the
virus was ﬁrst incubated at low pH, suggesting that a pH
dependent conformational change in the capsid was required for
membrane rupture. Heating the virus above 421 to release the
vertex proteins, also caused the virus to partially uncoat. Thus,
virus-induced liposome disruption occurred independent of low
pH when the capsid was ﬁrst exposed to elevated temperatures.
Therefore, the presumed pH dependence of adenovirus rupture of
cell membranes seemed to correlate with capsid uncoating rather
than with the actual process of membrane lytic activity.
Further, when the capsid was disrupted by incubation at
elevated temperature, the released proteins could be separated
from the partially disassembled virion by density gradient cen-
trifugation (Wiethoff et al., 2005). Membrane lytic activity was
present in the fraction of the soluble proteins rather than in the
partially disassembled capsid. Biochemically we observed that
these proteins were composed mostly of hexon, penton base, ﬁber,
IIIa and protein VI (Wiethoff et al., 2005). Further studies showed
that protein IX and protein VIII were incompletely released from
the capsid as well (C.M. Wiethoff, unpublished observation).
in vitro membrane lytic activity was not observed with the
puriﬁed hexon, recombinant penton base, or the ﬁber knob.
Therefore, we examined the primary sequences of other capsid
proteins such as protein IIIa and VI. A highly-conserved amphi-
pathic helix domain was found to be present in protein VI at
residues 34–54, immediately following the cleavage site processed
by the virally encoded 23 K cysteine protease.
To determine whether protein VI actually possessed the mem-
brane lytic activity, we immunodepleted protein VI or penton base
from the mixture of heat-released proteins and found that only
protein VI immunodepletion reduced the membrane lytic activity
of from this mixture of released vertex proteins. Recombinant
protein VI possessed the same pH-independent membrane lytic
activity as heat disrupted adenovirus virions and the N-terminal
amphiphathic helix in protein VI was required for this membrane
lytic activity. Subsequent studies demonstrated that antibodies to
protein VI abrogated adenovirus-mediated membrane permeabi-
lization as well as the delivery of the adenovirus genome to the
nucleus (Maier et al., 2010). Genetic manipulation of the amphi-
pathic alpha helix in the context of adenovirus provided further
evidence that protein VI was involved in adenovirus membrane
penetration. A mutant virus with single point mutation in protein
VI, L40Q, is defective in endosomal escape and the corresponding
recombinant L40Q mutant protein has reduced membrane binding
and liposome-disrupting activity in vitro (Moyer et al., 2011).
Biochemistry of membrane disruption by VI
While initial studies determined that an N-terminal helix from
residues 34–53 was required for protein VI membrane lytic activity,
the mechanism by which protein VI ruptured membranes remained
incompletely characterized. All evidence in vitro and in tissue culture
suggested that membrane damage by adenovirus is catastrophic,
allowing for the passage of a 90 nm virion through the membrane.
Given the biochemical copy number of protein VI, it is unlikely that a
stable pore of that size would be possible. A better understanding of
protein VI membrane lytic activity required further study.
Investigations using recombinant proteins demonstrated that
this helix was a critical determinant for binding to model liposo-
mal membranes (Maier et al., 2010). When this N-terminal
amphipathic α-helix is replaced by a 6xHis tag the membrane
binding capacity is reduced 40-fold and membrane lytic activity is
reduced by 100-fold (Maier et al., 2010). However, if membrane
afﬁnity of this 6xHis-tag-replaced protein VI is artiﬁcially
enhanced by using liposomes containing NTA-Ni2þ headgroups
for binding to the 6xHis tag, then the membrane lytic activity of
the protein can be restored to normal levels (Maier and Wiethoff,
2010). Further genetic evidence that this N-terminal amphipathic
α-helix is required for membrane binding and rupture was
obtained when L40 was mutated to glutamine, L40Q (Moyer
et al., 2011). This mutation led to a 10-fold reduction in recombi-
nant protein VI membrane afﬁnity as well as a 10-fold reduction in
in vitro membrane lytic activity. A recombinant E1, E3-deleted
human adenovirus 5 encoding the L40Q mutation in protein VI
was also found to be roughly 10-fold less infectious than virus
encoding the wild type protein. The decreased infectivity of the
L40Q mutant virus may also be related to an additional lability of
the capsid that causes it to release the receptor binding penton
prior to virus attachment to cells (Martinez et al., 2014).
The mechanism of protein VI membrane rupture remained uncer-
tain even after the proteinwas established as themembrane lytic factor
in the adenovirus capsid. To understand how protein VI ruptured
membranes, ﬂuorescence microscopy was used to visualize topological
changes in giant lipid vesicles upon protein VI binding. Within seconds
after addition of protein VI, these lipid vesicles are completely
fragmented. In many cases, these fragments are rearranged into
elongated tubules (Maier and Wiethoff, 2010), although the limits of
light microscopy spatial resolution has precluded further insights into
the structure of these tubules. Nonetheless, these observations ﬁt with
a model in which protein VI binds membranes and, much like a
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detergent, fragments the lipid bilayer into smaller, highly curved
structures. This is akin to how certain antimicrobial peptides might
rupture membranes (Domanov and Kinnunen, 2006) and involves the
induction of either severe positive or negative membrane curvature. In
the case of protein VI, incorporating small amounts of lysophosphati-
dylcholine, a molecule with a propensity to adopt positively curved
lipidic structures, enhanced protein VI membrane lysis. In contrast,
incorporating phosphatidylethanolamine, a molecule with a propensity
to adopt negatively curved lipidic structures, attenuated protein VI
membrane lysis (Maier et al., 2010). Thus, protein VI appears to
fragment membranes by binding to them and subjecting them to
severe positive curvature-inducing forces.
To understand how protein VI might be inducing positive
membrane curvature in lipid bilayers, studies were performed to
assess the topology of protein VI on lipid bilayers. A highly
conserved 80 residue domain at the N-terminus of protein VI is
85% α-helical as measured by CD spectrapolarimetry. Secondary
structure predictions suggest that this domain contains 4 α-helices
(Wiethoff et al., 2005). We used bromine atoms appended to
phospholipids to cause tryptophan ﬂuorescence quenching of
three tryptophan residues in the 80-residue VI amphipathic helix.
The extent of quenching depended on the depths or the trypto-
phan residues within the lipid bilayer. The data obtained in these
analyses suggested that protein VI penetrates lipid bilayers super-
ﬁcially, near the lipid headgroups (Maier et al., 2010). This type of
membrane topology is often observed for helical peptides that
induce positive membrane curvature (Epand and Epand, 2000). By
pushing apart the lipid headgroups to accommodate the protein,
one leaﬂet encounters substantial positive membrane curvature
stress.
A structure for a portion of this 80-residue α-helical domain of
protein VI was recently revealed in X-ray crystallographic studies
(Reddy and Nemerow, 2014). Interestingly, this domain in the
virus does not appear to possess the same degree of α-helicity as
that contained in the recombinant puriﬁed protein. It seems likely
that protein VI, following its release from the virus, must undergo
a signiﬁcant structural rearrangement upon membrane binding.
Further studies of the structure of protein VI on membranes and in
the capsid are needed to shed light on this possibility.
Structure and localization of protein VI in the HAdV capsid
The continued advancements in cryoEM, X-ray diffraction,
atomic force microscopy, and mass spectrometry techniques over
the past two decades have signiﬁcantly increased our knowledge
of adenovirus capsid structure as well as provided clues about the
processes of assembly and disassembly. Historically, the ﬁrst
animal virus protein to be crystallized (Franklin et al., 1971) and
then structurally characterized (Roberts et al., 1986) was the
hexon, the major outer capsid protein of adenovirus. These early
studies paved the way for subsequent cryoEM studies of adeno-
virus at 6 Å (Saban et al., 2006) and 10 Å resolution (Fabry et al.,
2005). These cryoEM structural studies of HAdV provided further
structural knowledge of this 90 nm (dia.) icosahedral virus includ-
ing the location of speciﬁc cement (minor) proteins IIIa and IX.
Unfortunately, the cryoEM density maps were not of sufﬁcient
resolution to deﬁnitively assign the location and interactions of all
of the capsid proteins including protein VI. This situation improved
after 3.5 Å resolution structures of HAdV were obtained by X-ray
diffraction (Reddy et al., 2010) and enhanced cryoEM techniques
(Liu et al., 2010). Complete agreement on the location and
structures of some of the cement proteins was not forthcoming
however. Recently, the location of protein VI in the virus capsid
and structure was determined by using advanced X-ray diffraction
techniques (Reddy and Nemerow, 2014) (Fig. 3). A signiﬁcant
portion of protein VI, residues 6–157, was revealed underneath
the vertex region closely associated with the peripentonal hexons.
Interestingly, the ﬁrst 33 amino acids of preprotein VI that are
cleaved by the viral cysteine protease, were seen buried inside the
cavity of the hexon trimer. This observation obtained by X-ray
diffraction was corroborated by mass spectrometry analyses that
revealed a pH dependent association of the amino terminal 33
residues of preprotein VI (pVIn) with the peripentonal hexons
(Snijder et al., 2014). In addition, hydrogen-deuterium exchanges
analyses indicated that up to 3 molecules of pVIn bind on the inner
surface of the hexon trimer (Snijder et al., 2014). Together these
studies suggested that the pVIn domain helps anchor the entire
Fig. 3. Interactions between protein VI and the PPHs. (A) A hybrid (surface and
tube) representation illustrating associations mediated by one copy of VI (red tube)
gluing the adjacent PPHs (1,10) and connecting them to hexon-40 arising from the
neighboring GON tile. The cleaved propeptide of VI (purple tube) remains
associated with PPH-1 inside the hexon cavity. Certain residues of VI are identiﬁed
with blue-colored labels. The penton base (PB) is shown in magenta. (B) A close-up
view of the propeptide (purple tube) interactions with PPH-1, shown as a gray
ribbon. A few residues that are involved in propeptide (purple) and hexon (green)
interactions are labeled. Names of hexon subunits (A and C) are shown in
parentheses. Reddy V S, and Nemerow G R. PNAS 2014;111:11715–11720.
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protein VI molecule inside the virus capsid. Cleavage of the amino
terminus of pVI (pVIn) during capsid maturation probably facil-
itates release of the membrane lytic domain during virus infection.
The remaining amino acid residues that represent the mature/
cleaved form of protein VI (a.a. 34–157) including the membrane
lytic domain (a.a. 34–54) are situated between neighboring
peripentonal hexons and help stabilize hexons on the inside of
the virus capsid (Fig. 3). Protein VI is also in close contact with two
other capsid proteins, V and VIII that together form a ternary
complex (VI–V–VIII) underneath the vertex. The protein VI fold
appears to be distinct and does not have any apparent structural
homologs. As mentioned earlier, residues 34–54 of VI that have
been predicted to form an amphipathic alpha helix (Wiethoff et al.,
2005), do not form a helical structure in the virus, however it is
possible that they adopt a helical conformation upon association
with host cell membranes.
A puzzling aspect of protein VI relates to its copy number in the
virus particle. Recent mass spectrometry analyses of HAdV using in
depth quantitative proteomics demonstrated that virions contain
360 copies of protein VI (Benevento et al., 2014). However the X-
ray structure of HAdV revealed only a maximum of 180 copies of
protein VI. One possibility that might explain this discrepancy is
that an additional 180 copies of protein VI are located in the inner
core of the virus and associated with the dsDNA genome. This
region of the virus is not icosahedarally ordered and thus it has not
been possible to analyze its structure. However, it is known that
protein VI and the C-terminus of this protein in particular, acts as a
molecular sled to facilitate the translocation of the viral cysteine
protease along DNA during virus capsid maturation (Blainey et al.,
2013; Baniecki et al., 2013).
The key function of protein VI is membrane disruption, a
process that requires virus disassembly in the early endosome to
expose this molecule (Nguyen et al., 2010). Recent atomic force
microscopy (AFM) studies have provided new information on the
biophysical properties of the viral capsid and how they relate to
capsid disassembly (Snijder et al., 2013). Using AFM in the
nanoindentation (also deﬁned as virus-poking) mode, the vertex
region of the virus containing the penton base and ﬁber was found
to be the least stable region of the capsid (Ortega-Esteban et al.,
2013). Moreover, AFM nanoindentation studies showed that the
binding of integrin αvβ5 to the penton base further softens the
capsid vertex region whereas the binding of a defensin HD5 has
precisely the opposite effect and strengthens the vertex. These
studies are consistent with previous cryoEM structural analyses
showing that αv integrin causes an untwisting of the penton base
(Lindert et al., 2009) whereas binding of defensing HD5 prevents
vertex removal and release of protein VI (Nguyen et al., 2010;
Smith et al., 2010).
These structural, biochemical and biophysical analyses have
shed further light on the molecular basis of virus assembly and
disassembly. However, further investigation is required to under-
stand precisely how pVI is released from the capsid and how it
undergoes conformational changes during membrane association.
Cell signaling and trafﬁcking events initiated by VI and
endosome disruption
Structural, biochemical and cell biological studies have pro-
vided important clues to the mechanisms involved in adenovirus
rupture and penetration of cellular membranes. However, little is
known of the host response to this assault, particularly on one of
the deﬁning features of the cell itself, cellular membranes. By all
accounts, adenovirus induces large membrane defects capable of
transmitting not only a 90 nm diameter viral particle, but many
soluble factor present near the membrane defect as well. Since
membrane integrity is a crucial aspect of normal cell physiology, it
is very likely that membrane damage is capable of being sensed by
the host. In other systems, pathogen-associated membrane
damage is met by a host stress response that triggers membrane
repair pathways (Tam et al., 2010; Gurcel et al., 2006). But it has
also been shown to trigger pathways leading to both innate and
adaptive immune activation (Thurston et al., 2012; Hara et al.,
2007). Thus adenovirus cell entry must somehow counterbalance
the responses mounted by the host upon virus induced membrane
damage.
Studies of the ts1 mutant provided some of the ﬁrst evidence
that membrane damage during adenovirus cell entry triggers a
stress response. This mutant virus is incapable of uncoating and
releasing protein VI to rupture cell membranes. Studies examining
the proinﬂammatory response to adenovirus in mice demon-
strated that while replication defective HAdV-C5 induces a very
rapid activation of the mitogen activated kinases, P38 and ERK,
these kinases were not activated early during infection with ts1
(Smith et al., 2011). Additional in vivo studies found that JNK1/2
activation in mice is dependent on capsid uncoating (Fejer et al.,
2008). These signaling pathways could be activated by sensing of
the viral DNA genome (Nociari et al., 2009) or early expression of
small virally associated, noncoding RNAs (Yamaguchi et al., 2010).
However, other studies have suggested that the viral capsid, acting
through αvβ3 integrins, is responsible for some of these responses
(Di Paolo et al., 2009; Chintakuntlawar et al., 2010; Higginbotham
et al., 2002).
More recently, adenovirus-induced membrane damage occur-
ring during entry of macrophages and dendritic cells was found to
activate an innate proﬂammatory signaling pathway leading to
augmented expression of proinﬂammtory cytokines and activation
of the NLRP3 inﬂammasome (Barlan et al., 2011; Muruve et al.,
2008). This pathway is related to the release of lysosomal cathe-
psins after adenovirus induced membrane damage (Barlan et al.,
2011). Cathepsin release is observed within minutes of membrane
damage and cathepsin-dependent events in the cytoplasm initiate
a mitochondrial stress pathway leading to increased oxidative
stress, all detectable within minutes after infection (McGuire et al.,
2011). This response is strongly correlated with the timing of
adenovirus membrane penetration (Greber et al., 1993) and does
not occur during infection with the ts1mutant (Barlan et al., 2011).
Interestingly, another nonenveloped virus thought to permeabilize
membranes during cell entry, reovirus, did not release lysosomal
cathepsins into the cytoplasm or induce oxidative stress signaling
in cells, suggesting the mechanism of adenoviruses cell membrane
penetration is much more catastrophic and thus capable of being
sensed by the host (Barlan et al., 2011).
Evidence that adenoviruses may have evolved strategies to
evade host detection of rupture of speciﬁc membrane compart-
ments is apparent from the fact that certain virus serotypes appear
to trafﬁc less efﬁciently to lysosomes prior to escape into the
cytoplasm than others. For example, subgroup A, B and D human
adenoviruses have been shown to trafﬁc more readily to lyso-
somes than subgroup C viruses (Shayakhmetov et al., 2003; Teigler
et al., 2014; Miyazawa et al., 1999). This trafﬁcking has been linked
to the receptor engaged by the ﬁber knob (Shayakhmetov et al.,
2003; Miyazawa et al., 1999). Barlan et al., found that in macro-
phages, an HAdV-C5 vector in which the ﬁber was swapped with
that of HAdV-B16 trafﬁcs more strongly to lysosomes, resulting in
greater release of lysosomal cathepsins than HAdV-C5 resulting in
greater inﬂammasome activation (Barlan et al., 2011). Thus, by
avoiding trafﬁcking to lysosomes prior to membrane rupture,
subgroup C viruses may have evolved a strategy to avoid triggering
innate signaling pathways designed to sense membrane damage.
Virus trafﬁcking to lysosomes in macrophages has also been
correlated with altered expression of integrins (Carey et al., 2007).
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In particular, expression of β5 integrin, shown previously to
augment the efﬁciciency of endosomal escape (Wickham et al.,
1994). αvβ5 expression is decreased upon activation of the
transcription factor, PU.1, making αvβ3 integrin the more abun-
dant integrin and this is correlated with increased viral trafﬁcking
to lysosomes (Berclaz et al., 2002). Interestingly, integrin αvβ3 has
been linked to greater activation of innate immune signaling in
macrophages (Di Paolo et al., 2009). However, it is not known
whether αvβ3 integrins usage leads to greater AdV trafﬁcking to
lysosomes, or that lysosomal membrane rupture is linked to the
inﬂammatory response to adenovirus observed in mice.
Another recently identiﬁed response to pathogen damage of
cell membranes involves the sensing of glycoprotein sugars
exposed to the cytoplasm upon membrane damage. A subset of
cytosolic molecules known as galectins have been recently shown
to bind to exodomains when pathogens such as Salmonella (Paz
et al., 2010) or Shigella (Dupont et al., 2009) bacteria or adeno-
viruses (Maier et al., 2012) invade host cells. One of these
molecules, galectin-8 has been shown to recruit the autophagy
cargo adapter molecule, NDP52 to damaged membranes and
target them for macroautophagy (Thurston et al., 2012). This form
of xenobiotic autophagy, xenophagy (Boyle and Randow, 2013),
has been shown to restrict bacterial replication in cells by target-
ing them for destruction by lysosomes. Further, autophagy has
been shown to be a key mechanism for facilitating antigen
presentation to T-cells from infected macrophages or dendritic
cells (Schmid et al., 2007).
Maier et al. recently found that galectins are recruited to
adenovirus ruptured membranes, much like they are recruited to
bacterial membranes (Maier et al., 2012). As with inﬂammasome
activation, another nonenveloped virus, reovirus, did not permea-
blize cell membranes in a manner that leads to galectin recruit-
ment (Maier et al., 2012). Thus, it appears that some nonenveloped
viruses may have evolved strategies to perturb cell membranes
without activating these immune detection pathways. Although
adenovirus membrane disruption recruits galectins, it is unclear
whether galectin-dependent xenophagy restricts adenovirus from
efﬁciently entering cells. In one report, starvation induced macro-
autophagy was found to augment AdV-C5 delivery and gene
expression (Zeng and Carlin, 2013). Thus, it remains to be deter-
mined whether adenovirus may have also evolved a strategy to
evade, or even usurp, autophagy to efﬁciently entry cells.
Adenovirus more potently activates innate immune signaling
pathways during cell entry, than other nonenveloped viruses
(Barlan et al., 2011; Paglino et al., 2014). Perhaps the physical size
and nature of the viral genome makes it unavoidable for AdV
activation of these pathways. Whatever the case, it appears that
AdVs have achieved a delicate balance between rupturing mem-
branes to enter cells and minimizing host cell sensing of this
damage or evading the responses to damaged membranes. Richard
Feynman once described the criticality experiment, in which
nuclear ﬁssion is initiated only just until a uncontrolled chain
reaction begins, as “tickling the tail of a sleeping dragon”. This
phrase seems an apt description of adenovirus penetration of
cellular membranes.
Unanswered questions and future endeavors
While signiﬁcant progress has been made in elucidating the
complex processes of adenovirus disassembly and membrane
penetration, numerous gaps remain in our understanding of the
details underlying these events. In particular, clues to the initial
steps in capsid uncoating have been gained from highly sophisti-
cated immunoﬂuorescence imaging studies (Burckhardt et al.,
2011) as well as biophysical (Snijder et al., 2013; Ortega-Esteban
et al., 2013), structural (Saban et al., 2006; Fabry et al., 2005;
Reddy et al., 2010; Liu et al., 2010) and functional analyses (Moyer
et al., 2011). However, we still lack precise information on the key
molecular events in virus disassembly. The proteins located at the
vertex region including penton base and ﬁber likely play central
roles in the initial disassembly. How these proteins undergo
conformational changes to disengage from the virion is still poorly
deﬁned. Further molecular genetic and structural analyses are
needed to help solve these mysteries.
With regards to membrane penetration, we now know the key
molecule in the virus, protein VI, that mediates this process
however the precise details of membrane disruption are not very
well understood as is the case for most non-enveloped viruses.
However, we now appreciate that the mechanism for adenovirus
membrane disruption is likely to be distinct from that used by
other non-enveloped viruses (Moyer and Nemerow, 2011). Viruses
such as parvovirus and reovirus induce transient lipid modiﬁca-
tions or size selective pore formation, respectively. The copy
number of protein VI in the virion, 360 per capsid, is now fairly
well established (Benevento et al., 2014), however whether all of
these are released upon capsid disassembly and whether a smaller
subset are adequate for membrane disruption has not been
determined. A structure for protein VI in the capsid has been
proposed and appears to be largely unstructured (Reddy and
Nemerow, 2014). However, the N-terminal 80 residues of mature
protein VI appear highly alpha-helical when bound to membranes.
Thus, possible conformational changes in protein VI following
capsid uncoating and membrane disruption need to be investi-
gated. Moreover, the functional consequences of protease cleavage
of protein VI near its amino terminus have yet to be fully
elucidated. These and other molecular details regarding virus cell
entry await further exploration. Given the role of adenoviruses in
human diseases and their uses in vaccine and gene therapy, a
failure to fully understand the process of adenovirus cell entry
risks awaking a sleeping dragon.
Acknowledgments
This is manuscript number 29014 from The Scripps Research
Institute. This work was supported by NIH R01 HL054352 (GRN)
and NIH RO1 AI100129 (CMW).
References
Amstutz, B., Gastaldelli, M., Kälin, S., Imelli, N., Boucke, K., Wandeler, E., Mercer, J.,
Hemmi, S., Greber, U.F., 2008. Subversion of CtBP1-controlled macropinocytosis
by human adenovirus serotype 3. EMBO J. 27, 956–969.
Arnberg, N., Edlund, K., Kidd, A.H., Wadell, G., 2000. Adenovirus type 37 uses sialic
acid as a cellular receptor. J. Virol. 74, 42–48.
Baniecki, M.L., McGrath, W.J., Mangel, W.F., 2013. Regulation of a viral proteinase by
a peptide and DNA in one-dimensional space: III. atomic resolution structure of
the nascent form of the adenovirus proteinase. J. Biol. Chem. 288, 2081–2091.
Barlan, A.U., Grifﬁn, T.M., McGuire, K.A., Wiethoff, C.M., 2011. Adenovirus mem-
brane penetration activates the NLRP3 inﬂammasome. J. Virol. 85, 146–155.
Benevento, M., Di Palma, S., Snijder, J., Moyer, C.L., Reddy, V.S., Nemerow, G.R., Heck,
A.J., 2014. Adenovirus composition, proteolysis, and disassembly studied by in-
depth qualitative and quantitative proteomics. J. Biol. Chem. 289, 11421–11430.
Berclaz, P.Y., Zsengellér, Z., Shibata, Y., Otake, K., Strasbaugh, S., Whitsett, J.A.,
Trapnell, B.C., 2002. Endocytic internalization of adenovirus, nonspeciﬁc
phagocytosis, and cytoskeletal organization are coordinately regulated in
alveolar macrophages by GM-CSF and PU.1. J. Immunol. 169, 6332–6342.
Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong,
J.S., Horwitz, M.S., Crowell, R.L., Finberg, R.W., 1997. Isolation of a common
receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275,
1320–1323.
Bewley, M.C., Springer, K., Zhang, Y.B., Freimuth, P., Flanagan, J.M., 1999. Structural
analysis of the mechanism of adenovirus binding to its human cellular receptor,
CAR. Science 286, 1579–1583.
Blainey, P.C., Graziano, V., Pérez-Berná, A.J., McGrath, W.J., Flint, S.J., San Martín, C.,
Xie, X.S., Mangel, W.F., 2013. Regulation of a viral proteinase by a peptide and
C.M. Wiethoff, G.R. Nemerow / Virology 479-480 (2015) 591–599 597
DNA in one-dimensional space: IV. viral proteinase slides along DNA to locate
and process its substrates. J. Biol. Chem. 288, 2092–2102.
Boyle, K.B., Randow, F., 2013. The role of ‘eat-me’ signals and autophagy cargo
receptors in innate immunity. Curr. Opin. Microbiol. 16, 339–348.
Brabec, M., Schober, D., Wagner, E., Bayer, N., Murphy, R.F., Blaas, D., Fuchs, R., 2005.
Opening of size-selective pores in endosomes during human rhinovirus
serotype 2 in vivo uncoating monitored by single-organelle ﬂow analysis. J.
Virol. 79, 1008–1016.
Burckhardt, C.J., Suomalainen, M., Schoenenberger, P., Boucke, K., Hemmi, S., Greber,
U.F., 2011. Drifting motions of the adenovirus receptor CAR and immobile
integrins initiate virus uncoating and membrane lytic protein exposure. Cell
Host Microbe 10, 105–117.
Burmeister, W.P., Guilligay, D., Cusack, S., Wadell, G., Arnberg, N., 2004. Crystal
structure of species D adenovirus ﬁber knobs and their sialic acid binding sites.
J. Virol. 78, 7727–7736.
Carey, B., Staudt, D., Bonaminio, D., van der Loo, J.C., Trapnell, B.C., 2007. PU.1
redirects adenovirus to lysosomes in alveolar macrophages, uncoupling inter-
nalization from infection. J. Immunol. 178, 2440–2447.
Chintakuntlawar, A.V., Zhou, X., Rajaiya, J., Chodosh, J., 2010. Viral capsid is a
pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog. 6,
e1000841.
Cotten, M., Weber, J.M., 1995. The adenovirus protease is required for virus entry
into host cells. Virology 213, 494–502.
Cupelli, K., Müller, S., Persson, B.D., Jost, M., Arnberg, N., Stehle, T., 2010. Structure of
adenovirus type 21 knob in complex with CD46 reveals key differences in
receptor contacts among species B adenoviruses. J. Virol. 84, 3189–3200.
Di Paolo, N.C., Miao, E.A., Iwakura, Y., Murali-Krishna, K., Aderem, A., Flavell, R.A.,
Papayannopoulou, T., Shayakhmetov, D.M., 2009. Virus binding to a plasma
membrane receptor triggers interleukin-1[alpha]-mediated proinﬂammatory
macrophage response in vivo. Immunity 31, 110–121.
Domanov, Y.A., Kinnunen, P.K., 2006. Antimicrobial peptides temporins B and L
induce formation of tubular lipid protrusions from supported phospholipid
bilayers. Biophys. J. 91, 4427–4439.
Dupont, N., Lacas-Gervais, S., Bertout, J., Paz, I., Freche, B., Van Nhieu, G.T., van der
Goot, F.G., Sansonetti, P.J., Lafont, F., 2009. Shigella phagocytic vacuolar
membrane remnants participate in the cellular response to pathogen invasion
and are regulated by autophagy. Cell Host Microbe 6, 137–149.
Epand, R.M., Epand, R.F., 2000. Modulation of membrane curvature by peptides.
Biopolymers 55, 358–363.
Excoffon, K.J., Gansemer, N.D., Mobily, M.E., Karp, P.H., Parekh, K.R., Zabner, J., 2010.
Isoform-speciﬁc regulation and localization of the coxsackie and adenovirus
receptor in human airway epithelia. PLoS One 5, e9909.
Fabry, C.M., Rosa-Calatrava, M., Conway, J.F., Zubieta, C., Cusack, S., Ruigrok, R.W.,
Schoehn, G., 2005. A quasi-atomic model of human adenovirus type 5 capsid.
EMBO J. 24, 1645–1654.
Farr, G.A., Zhang, L.G., Tattersall, P., 2005. Parvoviral virions deploy a capsid-
tethered lipolytic enzyme to breach the endosomal membrane during cell
entry. Proc. Natl. Acad. Sci. USA 102, 17148–17153.
Fejer, G., Drechsel, L., Liese, J., Schleicher, U., Ruzsics, Z., Imelli, N., Greber, U.F., Keck,
S., Hildenbrand, B., Krug, A., Bogdan, C., Freudenberg, M.A., 2008. Key role of
splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo.
PLoS Pathog. 4, e1000208.
FitzGerald, D.J., Padmanabhan, R., Pastan, I., Willingham, M.C., 1983. Adenovirus-
induced release of epidermal growth factor and pseudomonas toxin into the
cytosol of KB cells during receptor-mediated endocytosis. Cell 32, 607–617.
Franklin, R.M., Pettersson, U., Akervall, K., Strandberg, B., Philipson, L., 1971.
Structural proteins of adenovirus. V. Size and structure of the adenovirus type
2 hexon. J. Mol. Biol. 57, 383–395.
Gaggar, A., Shayakhmetov, D.M., Lieber, A., 2003. CD46 is a cellular receptor for
group B adenoviruses. Nat. Med. 9, 1408–1412.
Greber, U.F., Willetts, M., Webster, P., Helenius, A., 1993. Stepwise dismantling of
adenovirus 2 during entry into cells. Cell 75, 477–486.
Greber, U.F., Webster, P., Weber, J., Helenius, A., 1996. The role of the adenovirus
protease on virus entry into cells. EMBO J. 15, 1766–1777.
Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., van der Goot, F.G., 2006. Caspase-1
activation of lipid metabolic pathways in response to bacterial pore-forming
toxins promotes cell survival. Cell 126, 1135–1145.
Hannan, C., Raptis, L.H., Déry, C.V., Weber, J., 1983. Biological and structural studies
with an adenovirus type 2 temperature-sensitive mutant defective for uncoat-
ing. Intervirology 19, 213–223.
Hara, H., Kawamura, I., Nomura, T., Tominaga, T., Tsuchiya, K., Mitsuyama, M., 2007.
Cytolysin-dependent escape of the bacterium from the phagosome is required
but not sufﬁcient for induction of the Th1 immune response against Listeria
monocytogenes infection: distinct role of Listeriolysin O determined by
cytolysin gene replacement. Infect. Immun. 75, 3791–3801.
Higginbotham, J.N., Seth, P., Blaese, R.M., Ramsey, W.J., 2002. The release of
inﬂammatory cytokines from human peripheral blood mononuclear cells
in vitro following exposure to adenovirus variants and capsid. Hum. Gene
Ther. 13, 129–141.
Kalyuzhniy, O., Di Paolo, N.C., Silvestry, M., Hofherr, S.E., Barry, M.A., Stewart, P.L.,
Shayakhmetov, D.M., 2008. Adenovirus serotype 5 hexon is critical for virus
infection of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 105, 5483–5488.
King, A.M.Q., Adams, M.J., Carstens, E.B., 2012. Virus Taxonomy: Classiﬁcation and
Nomenclature of Viruses. Elsevier: Academic press, Amsterdam.
Li, E., Stupack, D., Klemke, R., Cheresh, D.A., Nemerow, G.R., 1998. Adenovirus
endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J.
Virol. 72, 2055–2061.
Lindert, S., Silvestry, M., Mullen, T.-M., Nemerow, G.R., Stewart, P.L., 2009. Cryo-
electron microscopy structure of an adenovirus-integrin complex indicates
conformational changes in both penton base and integrin. J. Virol. 83,
11491–11501.
Lion, T., 2014. Adenovirus infections in immunocompetent and immunocompro-
mised patients. Clin. Microbiol. Rev. 27, 441–462.
Liu, E.B., Wadford, D.A., Seto, J., Vu, M., Hudson, N.R., Thrasher, L., Torres, S., Dyer, D.
W., Chodosh, J., Seto, D., Jones, M.S., 2012. Computational and serologic analysis
of novel and known viruses in species human adenovirus D in which serology
and genomics do not correlate. PLoS One 7, e33212.
Liu, H., Jin, L., Koh, S., Atanasov, I., Schein, S., Wu, L., Zhou, Z., 2010. Atomic structure
of human adenovirus by cryo-EM reveals interactions among protein networks.
Science (New York, NY) 329, 1038–1043.
Maier, O., Wiethoff, C.M., 2010. N-terminal α-helix-independent membrane inter-
actions facilitate adenovirus protein VI induction of membrane tubule forma-
tion. Virology 408, 31–38.
Maier, O., Galan, D.L., Wodrich, H., Wiethoff, C.M., 2010. An N-terminal domain of
adenovirus protein VI fragments membranes by inducing positive membrane
curvature. Virology 402, 11–19.
Maier, O., Marvin, S.A., Wodrich, H., Campbell, E.M., Wiethoff, C.M., 2012. Spatio-
temporal dynamics of adenovirus membrane rupture and endosomal escape. J.
Virol. 86, 10821–10828.
Martinez, R., Schellenberger, P., Vasishtan, D., Aknin, C., Austin, S., Dacheux, D.,
Rayne, F., Siebert, A., Ruzsics, Z., Gruenewald, K., Wodrich, H., 2014. THE
amphipathic helix of adenovirus capsid protein vi contributes to penton release
and post entry sorting. J. Virol..
McGuire, K.A., Barlan, A.U., Grifﬁn, T.M., Wiethoff, C.M., 2011. Adenovirus type
5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress
and production of reactive oxygen species. J. Virol. 85, 10806–10813.
Miles, B.D., Luftig, R.B., Weatherbee, J.A., Weihing, R.R., Weber, J., 1980. Quantitation
of the interaction between adenovirus types 2 and 5 and microtubules inside
infected cells. Virology 105, 265–269.
Miyazawa, N., Leopold, P.L., Hackett, N.R., Ferris, B., Worgall, S., Falck-Pedersen, E., Crystal,
R.G., 1999. Fiber swap between adenovirus subgroups B and C alters intracellular
trafﬁcking of adenovirus gene transfer vectors. J. Virol. 73, 6056–6065.
Morgan, C., Rosenkranz, H.S., Mednis, B., 1969. Structure and development of
viruses as observed in the electron microscope. V. Entry and uncoating of
adenovirus. J. Virol. 4, 777–796.
Moyer, C.L., Nemerow, G.R., 2011. Viral weapons of membrane destruction: variable
modes of membrane penetration by non-enveloped viruses. Curr. Opin. Virol. 1,
44–449.
Moyer, C.L., Wiethoff, C.M., Maier, O., Smith, J.G., Nemerow, G.R., 2011. Functional
genetic and biophysical analyses of membrane disruption by human adeno-
virus. J. Virol. 85, 2631–2641.
Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J.,
Tschopp, J., 2008. The inﬂammasome recognizes cytosolic microbial and host
DNA and triggers an innate immune response. Nature 452, 103–107.
Nguyen, E.K., Nemerow, G.R., Smith, J.G., 2010. Direct evidence from single-cell
analysis that human {alpha}-defensins block adenovirus uncoating to neutra-
lize infection. J. Virol. 84, 4041–4049.
Nilsson, E.C., Storm, R.J., Bauer, J., Johansson, S.M., Lookene, A., Ångström, J.,
Hedenström, M., Eriksson, T.L., Frängsmyr, L., Rinaldi, S., Willison, H.J., Pedrosa
Domellöf, F., Stehle, T., Arnberg, N., 2011. The GD1a glycan is a cellular receptor
for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17, 105–109.
Nociari, M., Ocheretina, O., Murphy, M., Falck-Pedersen, E., 2009. Adenovirus
induction of IRF3 occurs through a binary trigger targeting Jun N-terminal
kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J.
Virol. 83, 4081–4091.
Ortega-Esteban, A., Pérez-Berná, A.J., Menéndez-Conejero, R., Flint, S.J., San Martín,
C., de Pablo, P.J., 2013. Monitoring dynamics of human adenovirus disassembly
induced by mechanical fatigue. Sci. Rep. 3 (1434).
Pache, L., Venkataraman, S., Reddy, V.S., Nemerow, G.R., 2008. Structural variations
in species B adenovirus ﬁbers impact CD46 association. J. Virol. 82, 7923–7931.
Paglino, J.C., Andres, W., van den Pol, A.N., 2014. Autonomous parvoviruses neither
stimulate nor are inhibited by the type I interferon response in human normal
or cancer cells. J. Virol. 88, 4932–4942.
Paz, I., Sachse, M., Dupont, N., Mounier, J., Cederfur, C., Enninga, J., Lefﬂer, H., Poirier,
F., Prevost, M.C., Lafont, F., Sansonetti, P., 2010. Galectin-3, a marker for vacuole
lysis by invasive pathogens. Cell. Microbiol. 12, 530–544.
Pérez, L., Carrasco, L., 1994. Involvement of the vacuolar H(þ)-ATPase in animal
virus entry. J. Gen. Virol. 75 (Pt 10), 2595–2606.
Persson, B.D., Reiter, D.M., Marttila, M., Mei, Y.-F., Casasnovas, J.M., Arnberg, N.,
Stehle, T., 2007. Adenovirus type 11 binding alters the conformation of its
receptor CD46. Nat. Struct. Mol. Biol. 14, 164–166.
Prchla, E., Plank, C., Wagner, E., Blaas, D., Fuchs, R., 1995. Virus-mediated release of
endosomal content in vitro: different behavior of adenovirus and rhinovirus
serotype 2. J. Cell Biol. 131, 111–123.
van Raaij, M.J., Mitraki, A., Lavigne, G., Cusack, S., 1999. A triple beta-spiral in the
adenovirus ﬁbre shaft reveals a new structural motif for a ﬁbrous protein.
Nature 401, 935–938.
Raper, S.E., Chirmule, N., Lee, F.S., Wivel, N.A., Bagg, A., Gao, G.-p., Wilson, J.M.,
Batshaw, M.L., 2003. Fatal systemic inﬂammatory response syndrome in a
C.M. Wiethoff, G.R. Nemerow / Virology 479-480 (2015) 591–599598
ornithine transcarbamylase deﬁcient patient following adenoviral gene trans-
fer. Mol. Gen. Metab. 80, 148–158.
Reddy, V.S., Nemerow, G.R., 2014. Structures and organization of adenovirus
cement proteins provide insights into the role of capsid maturation in virus
entry and infection. Proc. Natl. Acad. Sci. USA 111, 11715–11720.
Reddy, V.S., Natchiar, S.K., Stewart, P.L., Nemerow, G.R., 2010. Crystal structure of
human adenovirus at 3.5 A resolution. Science 329, 1071–1075.
Roberts, M.M., White, J.L., Grütter, M.G., Burnett, R.M., 1986. Three-dimensional
structure of the adenovirus major coat protein hexon. Science 232, 1148–1151.
Rodríguez, E., Everitt, E., 1996. Adenovirus uncoating and nuclear establishment are
not affected by weak base amines. J. Virol. 70, 3470–3477.
Saban, S.D., Silvestry, M., Nemerow, G.R., Stewart, P.L., 2006. Visualization of alpha-
helices in a 6-angstrom resolution cryoelectron microscopy structure of
adenovirus allows reﬁnement of capsid protein assignments. J. Virol. 80,
12049–12059.
Salinas, S., Bilsland, L.G., Henaff, D., Weston, A.E., Keriel, A., Schiavo, G., Kremer, E.J.,
2009. CAR-associated vesicular transport of an adenovirus in motor neuron
axons. PLoS Pathog. 5, e1000442.
Salinas, S., Zussy, C., Loustalot, F., Henaff, D., Menendez, G., Morton, P.E., Parsons, M.,
Schiavo, G., Kremer, E.J., 2014. Disruption of the coxsackievirus and adenovirus
receptor-homodimeric interaction triggers lipid microdomain- and dynamin-
dependent endocytosis and lysosomal targeting. J. Biol. Chem. 289, 680–695.
Schagen, F.H.E., Wensveen, F.M., Carette, J.E., Dermody, T.S., Gerritsen, W.R., van
Beusechem, V.W., 2006. Genetic targeting of adenovirus vectors using a
reovirus [sigma]1-Based attachment protein. Mol. Ther. 13, 997–1005.
Schmid, D., Pypaert, M., Münz, C., 2007. Antigen-loading compartments for major
histocompatibility complex class II molecules continuously receive input from
autophagosomes. Immunity 26, 79–92.
Seiradake, E., Lortat-Jacob, H., Billet, O., Kremer, E.J., Cusack, S., 2006. Structural and
mutational analysis of human Ad37 and canine adenovirus 2 ﬁber heads in
complex with the D1 domain of coxsackie and adenovirus receptor. J. Biol.
Chem. 281, 33704–33716.
Seth, P., 1994. Adenovirus-dependent release of choline from plasma membrane
vesicles at an acidic pH is mediated by the penton base protein. J. Virol. 68,
1204–1206.
Seth, P., Willingham, M.C., Pastan, I., 1984. Adenovirus-dependent release of 51Cr
from KB cells at an acidic pH. J. Biol. Chem. 259, 14350–14353.
Seth, P., Fitzgerald, D.J., Willingham, M.C., Pastan, I., 1984. Role of a low-pH
environment in adenovirus enhancement of the toxicity of a Pseudomonas
exotoxin-epidermal growth factor conjugate. J. Virol. 51, 650–655.
Seth, P., Pastan, I., Willingham, M.C., 1985. Adenovirus-dependent increase in cell
membrane permeability. J. Biol. Chem. 260, 9598–9602.
Shayakhmetov, D.M., Li, Z.Y., Ternovoi, V., Gaggar, A., Gharwan, H., Lieber, A., 2003.
The interaction between the ﬁber knob domain and the cellular attachment
receptor determines the intracellular trafﬁcking route of adenoviruses. J. Virol.
77, 3712–3723.
Silvestry, M., Lindert, S., Smith, J.G., Maier, O., Wiethoff, C.M., Nemerow, G.R.,
Stewart, P.L., 2009. Cryo-electron microscopy structure of adenovirus type 2
temperature-sensitive mutant 1 reveals insight into the cell entry defect. J.
Virol. 83, 7375–7383.
Smith, J.G., Silvestry, M., Lindert, S., Lu, W., Nemerow, G.R., Stewart, P.L., 2010.
Insight into the mechanisms of adenovirus capsid disassembly from studies of
defensin neutralization. PLoS Pathog. 6, e1000959.
Smith, J.S., Xu, Z., Tian, J., Palmer, D.J., Ng, P., Byrnes, A.P., 2011. The role of
endosomal escape and mitogen-activated protein kinases in adenoviral activa-
tion of the innate immune response. PLoS One 6, e26755.
Smith, T.A., 2003. Adenovirus serotype 5 ﬁber shaft inﬂuences in vivo gene transfer
in mice. Hum. Gene Ther. 14, 777–787.
Snijder, J., Reddy, V.S., May, E.R., Roos, W.H., Nemerow, G.R., Wuite, G.J., 2013.
Integrin and defensin modulate the mechanical properties of adenovirus. J.
Virol. 87, 2756–2766.
Snijder, J., Benevento, M., Moyer, C.L., Reddy, V., Nemerow, G.R., Heck, A.J., 2014. The
cleaved N-terminus of pVI binds peripentonal hexons in mature adenovirus. J.
Mol. Biol. 426, 1971–1979.
Stewart, P.L., Chiu, C.Y., Huang, S., Muir, T., Zhao, Y., Chait, B., Mathias, P., Nemerow,
G.R., 1997. Cryo-EM visualization of an exposed RGD epitope on adenovirus
that escapes antibody neutralization. EMBO J. 16, 1189–1198.
Tam, C., Idone, V., Devlin, C., Fernandes, M.C., Flannery, A., He, X., Schuchman, E.,
Tabas, I., Andrews, N.W., 2010. Exocytosis of acid sphingomyelinase by
wounded cells promotes endocytosis and plasma membrane repair. J. Cell Biol.
189, 1027–1038.
Teigler, J.E., Kagan, J.C., Barouch, D.H., 2014. Late endosomal trafﬁcking of alter-
native serotype adenovirus vaccine vectors augments antiviral innate immu-
nity. J. Virol. 88, 10354–10363.
Thurston, T.L., Wandel, M.P., von Muhlinen, N., Foeglein, A., Randow, F., 2012.
Galectin 8 targets damaged vesicles for autophagy to defend cells against
bacterial invasion. Nature 482, 414–418.
Waddington, S.N., McVey, J.H., Bhella, D., Parker, A.L., Barker, K., Atoda, H., Pink, R.,
Buckley, S.M., Greig, J.A., Denby, L., Custers, J., Morita, T., Francischetti, I.M.,
Monteiro, R.Q., Barouch, D.H., van Rooijen, N., Napoli, C., Havenga, M.J., Nicklin,
S.A., Baker, A.H., 2008. Adenovirus serotype 5 hexon mediates liver gene
transfer. Cell 132, 397–409.
Walters, R.W., Grunst, T., Bergelson, J.M., Finberg, R.W., Welsh, M.J., Zabner, J., 1999.
Basolateral localization of ﬁber receptors limits adenovirus infection from the
apical surface of airway epithelia. J. Biol Chem. 274, 10219–10226.
Walters, R.W., Freimuth, P., Moninger, T.O., Ganske, I., Zabner, J., Welsh, M.J., 2002.
Adenovirus ﬁber disrupts CAR-mediated intercellular adhesion allowing virus
escape. Cell 110, 789–799.
Wang, H., Li, Z.Y., Liu, Y., Persson, J., Beyer, I., Möller, T., Koyuncu, D., Drescher, M.R.,
Strauss, R., Zhang, X.B., Wahl, J.K., Urban, N., Drescher, C., Hemminki, A., Fender,
P., Lieber, A., 2011. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11
and 14. Nat. Med. 17, 96–104.
Wang, K., Huang, S., Kapoor-Munshi, A., Nemerow, G., 1998. Adenovirus inter-
nalization and infection require dynamin. J. Virol. 72, 3455–3458.
Wickham, T.J., Mathias, P., Cheresh, D.A., Nemerow, G.R., 1993. Integrins alpha v
beta 3 and alpha v beta 5 promote adenovirus internalization but not virus
attachment. Cell 73, 309–319.
Wickham, T.J., Filardo, E.J., Cheresh, D.A., Nemerow, G.R., 1994. Integrin alpha v beta
5 selectively promotes adenovirus mediated cell membrane permeabilization. J.
Cell Biol. 127, 257–264.
Wiethoff, C.M., Wodrich, H., Gerace, L., Nemerow, G.R., 2005. Adenovirus protein VI
mediates membrane disruption following capsid disassembly. J. Virol. 79,
1992–2000.
Wu, E., Trauger, S.A., Pache, L., Mullen, T.-M., von Seggern, D.J., Siuzdak, G.,
Nemerow, G.R., 2004. Membrane cofactor protein is a receptor for adenoviruses
associated with epidemic keratoconjunctivitis. J. Virol. 78, 3897–3905.
Xu, Z., Qiu, Q., Tian, J., Smith, J.S., Conenello, G.M., Morita, T., Byrnes, A.P., 2013.
Coagulation factor X shields adenovirus type 5 from attack by natural
antibodies and complement. Nat. Med. 19, 452–457.
Yamaguchi, T., Kawabata, K., Kouyama, E., Ishii, K.J., Katayama, K., Suzuki, T.,
Kurachi, S., Sakurai, F., Akira, S., Mizuguchi, H., 2010. Induction of type I
interferon by adenovirus-encoded small RNAs. Proc. Natl. Acad. Sci. USA 107,
17286–17291.
Zabner, J., Freimuth, P., Puga, A., Fabrega, A., Welsh, M.J., 1997. Lack of high afﬁnity
ﬁber receptor activity explains the resistance of ciliated airway epithelia to
adenovirus infection. J. Clin. Invest. 100, 1144–1149.
Zeng, X., Carlin, C.R., 2013. Host cell autophagy modulates early stages of
adenovirus infections in airway epithelial cells. J. Virol. 87, 2307–2319.
Zubieta, C., Schoehn, G., Chroboczek, J., Cusack, S., 2005. The structure of the human
adenovirus 2 penton. Mol. Cell 17, 121–135.
C.M. Wiethoff, G.R. Nemerow / Virology 479-480 (2015) 591–599 599
